Eris Lifesciences was founded by Mr Amit Bakshi and team in 2007.
Eris has outpaced the Indian Pharmaceutical Market (IPM) growth with a CAGR of 24.1% in Chronic and 14.1% in Acute therapy segment. Chronic category contributes to over 62.4% of our revenues as compared to 34.8% contribution to the IPM. Eris is the second fastest growing company in Chronic therapy amongst the top 25 companies.
Since its inception, Eris has rapidly climbed the ranking to 26th in 2018. In the process, Eris has launched numerous products and acquired multiple companies in the health sector to expand its operations and provide state-of-the-art products and services for its customers.